Furthermore, in the study by Martin et al. (involving 279 invasive breast cancer patients and 558 matched controls, followed for an average of 10 years), serum apoA-I concentrations were positively linked to breast cancer risk [18]. This evidence concerns the gene APOA1 and breast carcinoma.